Found: 49
Select item for more details and to access through your institution.
Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
- Published in:
- Clinical Breast Cancer, 2016, v. 16, n. 5, p. 418, doi. 10.1016/j.clbc.2016.05.004
- By:
- Publication type:
- Article
72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 455, doi. 10.1007/s10549-021-06276-7
- By:
- Publication type:
- Article
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 107, doi. 10.1007/s10549-021-06179-7
- By:
- Publication type:
- Article
Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 75, doi. 10.1007/s10549-019-05222-y
- By:
- Publication type:
- Article
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 627, doi. 10.1007/s10549-018-05120-9
- By:
- Publication type:
- Article
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 533, doi. 10.1007/s10549-018-5020-7
- By:
- Publication type:
- Article
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 33, doi. 10.1007/s10549-018-4812-0
- By:
- Publication type:
- Article
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 1, p. 310, doi. 10.1245/s10434-020-08735-9
- By:
- Publication type:
- Article
One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 1, p. 78, doi. 10.1245/s10434-015-4693-y
- By:
- Publication type:
- Article
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Highly sensitive detection of <italic>ESR1</italic> mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 49, doi. 10.1007/s10549-017-4487-y
- By:
- Publication type:
- Article
A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 1, p. 55, doi. 10.1007/s10549-017-4382-6
- By:
- Publication type:
- Article
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 2, p. 231, doi. 10.1007/s10549-017-4190-z
- By:
- Publication type:
- Article
Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 1, p. 55, doi. 10.1007/s10549-016-3801-4
- By:
- Publication type:
- Article
Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 305, doi. 10.1007/s10549-015-3469-1
- By:
- Publication type:
- Article
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 2, p. 299, doi. 10.1007/s10549-015-3322-6
- By:
- Publication type:
- Article
Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 2, p. 299, doi. 10.1007/s10549-013-2640-9
- By:
- Publication type:
- Article
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 136, n. 1, p. 107, doi. 10.1007/s10549-012-2245-8
- By:
- Publication type:
- Article
14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 229, doi. 10.1007/s10549-012-1976-x
- By:
- Publication type:
- Article
Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 3, p. 633, doi. 10.1007/s10549-010-1145-z
- By:
- Publication type:
- Article
Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 106, n. 1, p. 11, doi. 10.1007/s10549-006-9465-8
- By:
- Publication type:
- Article
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 4, p. 1418, doi. 10.1002/cam4.3742
- By:
- Publication type:
- Article
Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 8, p. 1915, doi. 10.1002/cam4.1142
- By:
- Publication type:
- Article
Drainage of Tumor-Derived DNA into Sentinel Lymph Nodes in Breast Cancer Patients.
- Published in:
- Pathology & Oncology Research, 2019, v. 25, n. 4, p. 1635, doi. 10.1007/s12253-019-00618-z
- By:
- Publication type:
- Article
A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 16, p. 3682, doi. 10.1002/cncr.25953
- By:
- Publication type:
- Article
High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 3, p. 472, doi. 10.1002/cncr.25626
- By:
- Publication type:
- Article
Clinicopathological Analysis of Breast Ductal Carcinoma in situ with ALDH1-Positive Cancer Stem Cells.
- Published in:
- Oncology, 2013, v. 85, n. 4, p. 248, doi. 10.1159/000355476
- By:
- Publication type:
- Article
Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest<sup>™</sup> 95GC Breast in a multi‑institutional registry study.
- Published in:
- Oncology Letters, 2023, v. 25, n. 5, p. N.PAG, doi. 10.3892/ol.2023.13794
- By:
- Publication type:
- Article
LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 2595, doi. 10.3892/ol.2017.7535
- By:
- Publication type:
- Article
Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.
- Published in:
- Oncology Letters, 2014, v. 8, n. 1, p. 397, doi. 10.3892/ol.2014.2068
- By:
- Publication type:
- Article
Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study.
- Published in:
- Cancer Science, 2024, v. 115, n. 2, p. 611, doi. 10.1111/cas.16020
- By:
- Publication type:
- Article
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1369, doi. 10.1111/cas.14838
- By:
- Publication type:
- Article
Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-β-hydroxylase expression.
- Published in:
- Cancer Science, 2017, v. 108, n. 12, p. 2454, doi. 10.1111/cas.13416
- By:
- Publication type:
- Article
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
- Published in:
- Cancer Science, 2014, v. 105, n. 10, p. 1369, doi. 10.1111/cas.12506
- By:
- Publication type:
- Article
GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer.
- Published in:
- Cancer Science, 2012, v. 103, n. 5, p. 913, doi. 10.1111/j.1349-7006.2012.02231.x
- By:
- Publication type:
- Article
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 5, p. 898, doi. 10.1007/s12282-024-01602-5
- By:
- Publication type:
- Article
Investigation of recurrence prediction ability of EndoPredict<sup>®</sup> using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict<sup>®</sup> from microarray data from fresh-frozen to FFPE tissues
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 4, p. 593, doi. 10.1007/s12282-024-01573-7
- By:
- Publication type:
- Article
Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 4, p. 977, doi. 10.1007/s12282-021-01226-z
- By:
- Publication type:
- Article
Sentinel lymph node biopsy after introducing Twirl® breast markers into suspicious lymph nodes in breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 3, p. 772, doi. 10.1007/s12282-020-01195-9
- By:
- Publication type:
- Article
Multi-gene classifiers for prediction of recurrence in breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 1, p. 12, doi. 10.1007/s12282-015-0596-9
- By:
- Publication type:
- Article
Intracystic papilloma in the breast of a male given long-term phenothiazine therapy: A case report.
- Published in:
- Breast Cancer (13406868), 2006, v. 13, n. 1, p. 84, doi. 10.2325/jbcs.13.84
- By:
- Publication type:
- Article
Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer.
- Published in:
- Oncology Reports, 2021, v. 46, n. 4, p. N.PAG, doi. 10.3892/or.2021.8168
- By:
- Publication type:
- Article
Development of recurrence risk score using 95-gene classifier and its application to formalin-fixed paraffin-embedded tissues in ER-positive, HER2-negative and node-negative breast cancer.
- Published in:
- Oncology Reports, 2019, v. 42, n. 6, p. 2680, doi. 10.3892/or.2019.7358
- By:
- Publication type:
- Article
Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation.
- Published in:
- Oncology Reports, 2019, v. 42, n. 6, p. 2382, doi. 10.3892/or.2019.7363
- By:
- Publication type:
- Article
Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
- Published in:
- Oncology Reports, 2016, v. 36, n. 4, p. 2225, doi. 10.3892/or.2016.5004
- By:
- Publication type:
- Article
Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
- Published in:
- Oncology Reports, 2016, v. 35, n. 3, p. 1511, doi. 10.3892/or.2015.4489
- By:
- Publication type:
- Article